Sign in to view content

A Model to Predict the 3-Year Risk of Needing Treatment for Diabetic Macular Edema

Bobeck S Modjtahedi, MD

Video
Published 2018

Related

Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
Thomas A. Ciulla, MD, MBA, FASRS
Updates from the Field
2017
Future DME Therapeutics
Updates from the Field
2017
The Rise of Telemedicine in the COVID-19 era
Jayanth Sridhar, MD
Member Podcasts
2020

Category: Diabetic Retinopathy

See more